Joseph Michael Guenther Jr. MD
Breast, Surgical Oncology (Other than Breast)
Physician
Request appointment
20 Medical Village Dr Ste 254Edgewood, KY 41017
Fax+1 859-344-0091
Overview of Dr. Guenther
Dr. Joseph Guenther is a general surgeon in Edgewood, KY and is affiliated with St. Elizabeth Edgewood. He received his medical degree from University of Michigan Medical School and has been in practice 39 years. He is one of 23 doctors at St. Elizabeth Edgewood who specialize in General Surgery. He has 9 publications and over 450 citings.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Surgery, 1987 - 1992
University of Michigan Medical SchoolClass of 1987
Certifications & Licensure
CA State Medical License 1992 - Present
KY State Medical License 2002 - 2027
OH State Medical License 2001 - 2027
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Syndromic Surveillance Reporting, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- 5 citationsA prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced numbe...J Michael Guenther, Andrew Ward, Brian J Martin, Mark Cripe, Rohit Sharma
World Journal of Surgical Oncology. 2025-01-03 - 16 citationsEndocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or...Cynthia X Ma, Vera J Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag
JAMA Oncology. 2024-03-01 - 7 citationsPresurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial.Seema A Khan, Xinlei Mi, Yanfei Xu, Luis Z Blanco Jr, Azza M Akasha
JAMA Surgery. 2023-12-01
Press Mentions
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node PositivityNovember 14th, 2025- Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma TestApril 3rd, 2025
- Use of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024November 6th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
